These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37403295)

  • 1. Structural and functional effects of the L84S mutant in the SARS-COV-2 ORF8 dimer based on microsecond molecular dynamics study.
    Islam S; Parves MR; Islam MJ; Ali MA; Efaz FM; Hossain MS; Ullah MO; Halim MA
    J Biomol Struct Dyn; 2024 Jul; 42(11):5770-5787. PubMed ID: 37403295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.
    Ohki S; Imamura T; Higashimura Y; Matsumoto K; Mori M
    Biochem Biophys Res Commun; 2021 Jul; 563():92-97. PubMed ID: 34062392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the impact of ORF3a Q57H mutation on SARS-CoV-2: insights from molecular dynamics.
    Islam MJ; Alom MS; Hossain MS; Ali MA; Akter S; Islam S; Ullah MO; Halim MA
    J Biomol Struct Dyn; 2024 Nov; 42(18):9753-9766. PubMed ID: 37649361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ORF8 dimerization in SARS-CoV-2 delta variant leads to a better adaptive immune response due to abrogation of ORF8-MHC1 interaction.
    Chaudhari AM; Singh I; Joshi M; Patel A; Joshi C
    Mol Divers; 2023 Feb; 27(1):45-57. PubMed ID: 35243596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in SARS-CoV-2 ORF8 Altered the Bonding Network With Interferon Regulatory Factor 3 to Evade Host Immune System.
    Rashid F; Suleman M; Shah A; Dzakah EE; Wang H; Chen S; Tang S
    Front Microbiol; 2021; 12():703145. PubMed ID: 34335535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene.
    Pereira F
    Infect Genet Evol; 2020 Nov; 85():104525. PubMed ID: 32890763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8.
    Wu X; Xia T; Shin WJ; Yu KM; Jung W; Herrmann A; Foo SS; Chen W; Zhang P; Lee JS; Poo H; Comhair SAA; Jehi L; Choi YK; Ensser A; Jung JU
    mBio; 2022 Apr; 13(2):e0040222. PubMed ID: 35343786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural, energetic and lipophilic analysis of SARS-CoV-2 non-structural protein 9 (NSP9).
    de O Araújo J; Pinheiro S; Zamora WJ; Alves CN; Lameira J; Lima AH
    Sci Rep; 2021 Nov; 11(1):23003. PubMed ID: 34837010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 ORF8 dimerization and binding mode analysis with class I MHC: computational approaches to identify COVID-19 inhibitors.
    Selvaraj C; Dinesh DC; Pedone EM; Alothaim AS; Vijayakumar R; Rudhra O; Singh SK
    Brief Funct Genomics; 2023 Apr; 22(2):227-240. PubMed ID: 36827221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and dynamics of whole-sequence homology model of ORF3a protein of SARS-CoV-2: An insight from microsecond molecular dynamics simulations.
    Akter S; Islam MJ; Ali MA; Zakaria Tashrif M; Uddin MJ; Ullah MO; Halim MA
    J Biomol Struct Dyn; 2024 Aug; 42(13):6726-6739. PubMed ID: 37528650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of
    Ahmadi K; Shahbazi B; Zakeri AJ; Gouklani H
    J Biomol Struct Dyn; 2023; 41(21):11415-11430. PubMed ID: 36576175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein.
    Flower TG; Buffalo CZ; Hooy RM; Allaire M; Ren X; Hurley JH
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33361333
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cheng Y; Peng X
    Phys Chem Chem Phys; 2022 Jul; 24(27):16876-16883. PubMed ID: 35788229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation.
    Wu F; Chen X; Ma Y; Wu Y; Li R; Huang Y; Zhang R; Zhou Y; Zhan J; Liu S; Xu W
    Microbiol Spectr; 2023 Aug; 11(4):e0123423. PubMed ID: 37318366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of SARS-CoV-2
    Alkhansa A; Lakkis G; El Zein L
    Gene Rep; 2021 Jun; 23():101024. PubMed ID: 33490718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
    Zinzula L
    Biochem Biophys Res Commun; 2021 Jan; 538():116-124. PubMed ID: 33685621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 ORF8 modulates lung inflammation and clinical disease progression.
    McGrath ME; Xue Y; Taylor L; Dillen C; Ardanuy J; Gonzalez-Juarbe N; Baracco L; Kim R; Hart R; Assad-Garcia N; Vashee S; Frieman MB
    PLoS Pathog; 2024 May; 20(5):e1011669. PubMed ID: 38781259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal Structures of Bat and Human Coronavirus ORF8 Protein Ig-Like Domain Provide Insights Into the Diversity of Immune Responses.
    Chen X; Zhou Z; Huang C; Zhou Z; Kang S; Huang Z; Jiang G; Hong Z; Chen Q; Yang M; He S; Liu S; Chen J; Li K; Li X; Liao J; Chen J; Chen S
    Front Immunol; 2021; 12():807134. PubMed ID: 34975921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR.
    Laprise F; Arduini A; Duguay M; Pan Q; Liang C
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.